Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide/Dexamethasone Induction and Sequential Maintenance in High-risk Multiple Myeloma
NCT00691704Phase 2Completed
- Start
- Aug 2008
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in multiple myeloma (MM). Started Aug 2008; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00691704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00691704.